Nectar Lifesciences Future Growth
Future criteria checks 0/6
We currently don't have sufficient analyst coverage to forecast growth and revenue for Nectar Lifesciences.
Key information
n/a
Earnings growth rate
n/a
EPS growth rate
Pharmaceuticals earnings growth | 18.1% |
Revenue growth rate | n/a |
Future return on equity | n/a |
Analyst coverage | None |
Last updated | n/a |
Recent future growth updates
No updates
Recent updates
Nectar Lifesciences Limited (NSE:NECLIFE) Shares Fly 31% But Investors Aren't Buying For Growth
Aug 22Here's Why Nectar Lifesciences (NSE:NECLIFE) Has A Meaningful Debt Burden
Jul 27Nectar Lifesciences Limited (NSE:NECLIFE) Stock Catapults 27% Though Its Price And Business Still Lag The Industry
Feb 19Does Nectar Lifesciences (NSE:NECLIFE) Have A Healthy Balance Sheet?
Dec 22Nectar Lifesciences (NSE:NECLIFE) Has Debt But No Earnings; Should You Worry?
Jun 16Nectar Lifesciences (NSE:NECLIFE) Takes On Some Risk With Its Use Of Debt
Jun 21Nectar Lifesciences (NSE:NECLIFE) Takes On Some Risk With Its Use Of Debt
Jul 29Is Nectar Lifesciences Limited (NSE:NECLIFE) A Risky Dividend Stock?
Feb 25Nectar Lifesciences (NSE:NECLIFE) Has A Somewhat Strained Balance Sheet
Jan 21Zooming in on NSE:NECLIFE's 0.3% Dividend Yield
Nov 02Does Nectar Lifesciences (NSE:NECLIFE) Have A Healthy Balance Sheet?
Sep 07If You Had Bought Nectar Lifesciences (NSE:NECLIFE) Stock A Year Ago, You Could Pocket A 47% Gain Today
Aug 09The Nectar Lifesciences (NSE:NECLIFE) Share Price Has Gained 47% And Shareholders Are Hoping For More
Aug 09What You Can Learn From Nectar Lifesciences Limited's (NSE:NECLIFE) P/E
Jul 13In this section we usually present revenue and earnings growth projections based on the consensus estimates of professional analysts to help investors understand the company’s ability to generate profit. But as Nectar Lifesciences has not provided enough past data and has no analyst forecast, its future earnings cannot be reliably calculated by extrapolating past data or using analyst predictions.
This is quite a rare situation as 97% of companies covered by SimplyWall St do have past financial data.
Earnings and Revenue Growth Forecasts
Date | Revenue | Earnings | Free Cash Flow | Cash from Op | Avg. No. Analysts |
---|---|---|---|---|---|
6/30/2024 | 16,493 | 61 | N/A | N/A | N/A |
3/31/2024 | 16,846 | 50 | 1,953 | 2,247 | N/A |
12/31/2023 | 16,322 | 81 | N/A | N/A | N/A |
9/30/2023 | 15,241 | -28 | 1,473 | 1,765 | N/A |
6/30/2023 | 15,148 | -263 | N/A | N/A | N/A |
3/31/2023 | 15,237 | -242 | 1,036 | 1,337 | N/A |
12/31/2022 | 16,120 | -162 | N/A | N/A | N/A |
9/30/2022 | 17,109 | 28 | 1,459 | 1,708 | N/A |
6/30/2022 | 16,868 | 272 | N/A | N/A | N/A |
3/31/2022 | 16,689 | 250 | 700 | 950 | N/A |
12/31/2021 | 15,421 | -276 | N/A | N/A | N/A |
9/30/2021 | 14,765 | -454 | 435 | 790 | N/A |
6/30/2021 | 15,387 | -546 | N/A | N/A | N/A |
3/31/2021 | 15,433 | -733 | -99 | 214 | N/A |
12/31/2020 | 17,586 | -249 | N/A | N/A | N/A |
9/30/2020 | 20,291 | -86 | 903 | 1,399 | N/A |
6/30/2020 | 21,807 | 12 | N/A | N/A | N/A |
3/31/2020 | 23,664 | 318 | 2,302 | 2,850 | N/A |
12/31/2019 | 25,973 | 419 | N/A | N/A | N/A |
9/30/2019 | 26,819 | 446 | 2,339 | 2,632 | N/A |
6/30/2019 | 28,274 | 480 | N/A | N/A | N/A |
3/31/2019 | 27,829 | 476 | 2,011 | 2,392 | N/A |
3/31/2018 | 18,763 | 523 | N/A | 652 | N/A |
3/31/2017 | 16,437 | 553 | N/A | 1,988 | N/A |
3/31/2016 | 16,757 | 542 | N/A | 1,688 | N/A |
3/31/2015 | 16,436 | 663 | N/A | 1,444 | N/A |
3/31/2014 | 16,383 | 621 | N/A | 2,549 | N/A |
Analyst Future Growth Forecasts
Earnings vs Savings Rate: Insufficient data to determine if NECLIFE's forecast earnings growth is above the savings rate (6.7%).
Earnings vs Market: Insufficient data to determine if NECLIFE's earnings are forecast to grow faster than the Indian market
High Growth Earnings: Insufficient data to determine if NECLIFE's earnings are expected to grow significantly over the next 3 years.
Revenue vs Market: Insufficient data to determine if NECLIFE's revenue is forecast to grow faster than the Indian market.
High Growth Revenue: Insufficient data to determine if NECLIFE's revenue is forecast to grow faster than 20% per year.
Earnings per Share Growth Forecasts
Future Return on Equity
Future ROE: Insufficient data to determine if NECLIFE's Return on Equity is forecast to be high in 3 years time